Metabolic disorders in kidney stone disease in children
DOI:
https://doi.org/10.12775/JEHS.2020.10.03.017Keywords
nephrolithiasis, metabolic, hipercalciuriaAbstract
Urolithiasis is not a rare disorder in children. Its etiology, incidence and localization vary by geographic region. It is an increasing problem, especially in developing countries. Metabolic abnormalities have been claimed to play a significant role in the kidney stone disease. Most of the studies confirmed that hypercalciuria, hypocitraturia are the most commonly identified metabolic disorder in children with urolithiasis. It is important to evaluate them to modify and prevent the stone recurrence.References
Milliner DS, Murphy ME. Urolithiasis in Pediatric Patients. Mayo Clin Proc. 1993;68(3):241-248. doi:10.1016/S0025-6196(12)60043-3
Perrone HC, Rinaldi D, Santos MV, et al. Pediatric Nephrology Urolithiasis in childhood : metabolic evaluation. 1992:14-16.
Amato M, Lusini ML, Nelli F. Epidemiology of nephrolithiasis today. Urol Int. 2004;72(SUPPL. 1):1-5. doi:10.1159/000076582
Choi BH, Duckett JW. Urolithiasis in Childhood: Current Management. 1987;22(2):158-164.
Troup CW, Lawnicki CC, Bourne RB, Hodgson NB. Renal calculus in children. J Urol. 1972;107(2):306-307. doi:10.1016/S0022-5347(17)61011-5
Wilkinson H. Clinical investigation and management of patients with renal stones. Ann Clin Biochem. 2001;38(3):180-187. doi:10.1258/0004563011900623
Smith CK. Urinary calculi in children. J Am Med Assoc. 1928;91(19):1431-1435. doi:10.1001/jama.1928.02700190015005
Noe HN, Stapleton FB, Jerkins GR, Roy S. Clinical experience with urolithiasis. J Urol. 1983;129(6):1166-1168. doi:10.1016/S0022-5347(17)52622-1
Pietrow PK, Pope JC IV, Adams MC, et al. Clinical outcome of pediatric stone10. Hogg RJ, Reisch JS, Green K, et al. Idiopathic hypercalciuria: Association with isolated hematuria and risk for urolithiasis in children. Kidney Int. 1990;37(2):807-811. doi:10.1038/ki.1990.49
Vandervoort K, Wiesen J, Frank R, et al. Urolithiasis in Pediatric Patients : A Single Center Study of Incidence , Clinical Presentation and Outcome. 2007;177(June):2300-2305. doi:10.1016/j.juro.2007.02.002
Bihl G, Meyers A. Recurrent renal stone disease - Advances in pathogenesis and clinical management. Lancet. 2001;358(9282):651-656. doi:10.1016/S0140-6736(01)05782-8
Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis. Kidney Int Eval calcium oxalate monohydrate Cryst Kinet Vitr. 2009;75(6):585-595. doi:10.1038/ki.2008.626
Nicar MJ, Hill K, Pak CYC. Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro. J Bone Miner Res. 1987;2(3):215-220. doi:10.1002/jbmr.5650020308
Copelovitch L. Urolithiasis in Children. Medical Approach. Pediatr Clin North Am. 2012;59(4):881-896. doi:10.1016/j.pcl.2012.05.009
Burke C, Stickler B. Nephrolithiasis. 2020;(1).
Shah J, Whitfield HN. Urolithiasis through the ages. BJU Int. 2002;89(8):801-810. doi:10.1046/j.1464-410X.2002.02769.x
Ratkalkar VN, Kleinman JG. Mechanisms of stone formation. Clin Rev Bone Miner Metab. 2011;9(3-4):187-197. doi:10.1007/s12018-011-9104-8
Bilge I, Yilmaz A, Kayiran SM, et al. Clinical importance of renal calyceal microlithiasis in children. Pediatr Int. 2013;55(6):731-736. doi:10.1111/ped.12186
Güven AG, Koyun M. Urolithiasis in the first year of life. 2010:129-134. doi:10.1007/s00467-009-1296-5
Stapleton FB, McKay CP, Noe NH. Urolithiasis in children: the role of hypercalciuria. Pediatr Ann 1987;16:980–92
Assimos D. Re: Nephrolithiasis-Associated Bone Disease: Pathogenesis and Treatment Options. J Urol. 2011;185(5):1749-1749. doi:10.1016/s0022-5347(11)60193-6
Mir C, Rodriguez A, Rodrigo D, et al. Analysis of urine composition from split 24-h samples: use of 12-h overnight samples to evaluate risk factors for calcium stones in healthy and stone forming children. J Pediatr Urol. 2020. doi:10.1016/j.jpurol.2020.02.011
Benigno V, Canonica CS, Bettinelli A, Von Vigier RO, Truttmann AC, Bianchetti MG. Hypomagnesaemia-hypercalciuria-nephrocalcinosis: A report of nine cases and a review. Nephrol Dial Transplant. 2000;15(5):605-610. doi:10.1093/ndt/15.5.605
Jaya Kausalya P, Amasheh S, Günzel D, et al. Disease-associated mutations affect intracellular traffic and paracellular Mg2+ transport function of Claudin-16. J Clin Invest. 2006;116(4):878-891. doi:10.1172/JCI26323
Karet FE. Inherited distal renal tubular acidosis. J Am Soc Nephrol. 2002;13(8):2178-2184. doi:10.1097/01.ASN.0000023433.08833.88
Dhir G, Li D, Hakonarson H, Levine MA. Late-onset hereditary hypophosphatemic rickets with hypercalciuria (HHRH) due to mutation of SLC34A3/NPT2c. Bone. 2017;97:15-19. doi:10.1016/j.bone.2016.12.001
Tang AR, Hinz LE, Khan A, Kline GA. Phosphate matters when investigating hypercalcemia: A mutation in SLC34A3 causing HHRH. Endocrinol Diabetes Metab Case Reports. 2019;2019(1). doi:10.1530/EDM-19-0058
Cunha T da S, Heilberg IP. Bartter syndrome: Causes, diagnosis, and treatment. Int J Nephrol Renovasc Dis. 2018;11:291-301. doi:10.2147/IJNRD.S155397
Hebert SC. Bartter syndrome. Curr Opin Nephrol Hypertens. 2003;12(5):527-532. doi:10.1097/00041552-200309000-00008
Kok DJ, Papapoulos SE, Blomen LJMJ, Bijvoet OLM. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kidney Int. 1988;34(3):346-350. doi:10.1038/ki.1988.187
Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H. Metabolic Risk Factors in Pediatric and Adult Calcium Oxalate Urinary Stone Formers : Is There Any Difference ? 2003:273-277. doi:10.1159/000070134
Alon US, Zimmerman H, Alon M. Evaluation and treatment of pediatric idiopathic urolithiasis - Revisited. Pediatr Nephrol. 2004;19(5):516-520. doi:10.1007/s00467-004-1422-3
Lieske JC, Farell G, Deganello S. The effect of ions at the surface of calcium oxalate monohydrate crystals on cell-crystal interactions. Urol Res. 2004;32(2):117-123. doi:10.1007/s00240-003-0391-5
Spivacow FR, Negri AL, Valle EE, Calviño I, Fradinger E, Zanchetta JR. Metabolic risk factors in children with kidney stone disease. 2008:1129-1133. doi:10.1007/s00467-008-0769-2
Pak CYC, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int. 2001;60(2):757-761. doi:10.1046/j.1523-1755.2001.060002757.x
Menon M. Uric acid excretion in children with urolithiasis: Editorial comment. J Urol. 1990;144(2 I):406.
Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int Eval calcium oxalate monohydrate Cryst Kinet Vitr. 2001;59(1):270-276. doi:10.1046/j.1523-1755.2001.00488.x
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 443
Number of citations: 0
